Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04734106 · ClinicalTrials.gov registry record · Early Phase 1

Safety and Efficacy of Aloe Vera in the Management of the Symptoms of Interstitial Cystitis

A Early Phase 1 study of Interstitial Cystitis and Bladder Pain Syndrome, sponsored by Wake Forest University Health Sciences.

Recruiting
Registry status
Early Phase 1
Development phase
30
Enrollment target
1
Study location

NCT04734106 is a Early Phase 1 study of Interstitial Cystitis and Bladder Pain Syndrome that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 30 participants, below the 361-participant average among 26 other Interstitial Cystitis trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04734106, a Early Phase 1 study of Interstitial Cystitis and Bladder Pain Syndrome, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.

RECRUITING
Registry status
Early Phase 1
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess the safety and efficacy of super-concentrated, freeze-dried aloe vera capsules for treatment of interstitial cystitis.

Interventions

  • DRUG Desert Harvest Aloe Vera Capsules
  • OTHER Placebo Capsules

Study Locations (1)

North Carolina

  • Wake Forest Baptist Hospital - Winston-Salem

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2025-02-18
Est. Completion 2027-07
Phase Early Phase 1

Sponsor

Wake Forest University Health Sciences

1,140 total trials

What the Registry Record Tells You About NCT04734106

The ClinicalTrials.gov registry entry for NCT04734106 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 361-participant average among 26 other Interstitial Cystitis trials with a reported enrollment target (92% lower). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Interstitial Cystitis appearing as the primary indexed condition, and to 2 interventions - of which Desert Harvest Aloe Vera Capsules is the first listed.

NCT04734106 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT04734106 about?

NCT04734106 is a clinical study titled "Safety and Efficacy of Aloe Vera in the Management of the Symptoms of Interstitial Cystitis". The purpose of this study is to assess the safety and efficacy of super-concentrated, freeze-dried aloe vera capsules for treatment of interstitial cystitis.

What is the current status of trial NCT04734106?

This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 30 participants. The study started on 2025-02-18. Estimated completion is 2027-07.

What conditions does trial NCT04734106 study?

This clinical trial studies the following conditions: Interstitial Cystitis, Bladder Pain Syndrome, Chronic Interstitial Cystitis.

What interventions are being tested in trial NCT04734106?

The interventions under investigation include: Desert Harvest Aloe Vera Capsules (DRUG), Placebo Capsules (OTHER).

Who is sponsoring clinical trial NCT04734106?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04734106 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Interstitial Cystitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.